Merck & Co., Inc. Repayments of Long-Term Debt
Merck & Co., Inc. (MRK) reported Repayments of Long-Term Debt of $1.15 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-07
- Merck & Co., Inc. repayments of long-term debt for the quarter ending 2026-06-30 was $5.00M.
- Merck & Co., Inc. repayments of long-term debt for the quarter ending 2026-03-31 was $1.14B, a 54.40% decline year-over-year.
- Merck & Co., Inc. repayments of long-term debt for the quarter ending 2025-12-31 was $2.00M, a 99.63% decline year-over-year.
- Merck & Co., Inc. repayments of long-term debt for the quarter ending 2025-09-30 was $1.00M.
- Merck & Co., Inc. repayments of long-term debt for fiscal 2025 was $2.50B, a 94.03% increase from fiscal 2024.
- Merck & Co., Inc. repayments of long-term debt for fiscal 2024 was $1.29B, a 26.50% decline from fiscal 2023.
- Merck & Co., Inc. repayments of long-term debt for fiscal 2023 was $1.75B, a 22.03% decline from fiscal 2022.
- Merck & Co., Inc. repayments of long-term debt for fiscal 2022 was $2.25B, a 2.93% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 3 month as first filed | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 6 month as first filed | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 9 month as first filed | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.15B 10-Q · filed 2026-08-07 | $1.15B derived: sum of 3 quarters · filed 2026-08-07 | $1.15B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $1.14B 10-Q · filed 2026-05-04 | $1.14B derived: sum of 2 quarters · filed 2026-05-04 | $1.14B derived: sum of 3 quarters · filed 2026-05-04 | $1.14B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.00M derived: sum of 2 quarters · filed 2026-02-24 | $3.00M derived: sum of 3 quarters · filed 2026-08-07 | $2.50B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.00M derived: sum of 2 quarters · filed 2026-08-07 | $2.50B 10-Q · filed 2025-11-05 | $3.04B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $2.50B 10-Q · filed 2026-08-07 | $3.04B derived: sum of 3 quarters · filed 2026-08-07 | $3.04B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $2.50B 10-Q · filed 2026-05-04 | $3.04B derived: sum of 2 quarters · filed 2026-05-04 | $3.04B derived: sum of 3 quarters · filed 2026-05-04 | $3.04B derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $539.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $539.00M derived: sum of 2 quarters · filed 2026-02-24 | $539.00M derived: sum of 3 quarters · filed 2026-02-24 | $1.29B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $751.00M 10-Q · filed 2025-11-05 | $754.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $751.00M 10-Q · filed 2025-08-05 | $754.00M derived: sum of 3 quarters · filed 2026-02-24 | $755.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $751.00M 10-Q · filed 2025-05-02 | $754.00M derived: sum of 2 quarters · filed 2026-02-24 | $755.00M derived: sum of 3 quarters · filed 2026-02-24 | $2.50B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.00M derived: sum of 2 quarters · filed 2026-02-24 | $1.75B derived: sum of 3 quarters · filed 2026-02-24 | $1.75B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.75B derived: sum of 2 quarters · filed 2024-11-06 | $1.75B 10-Q · filed 2024-11-06 | $1.75B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $1.75B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.75B 10-Q · filed 2024-08-05 | $1.75B derived: sum of 3 quarters · filed 2025-02-25 | $2.75B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-03 | $2.00M derived: sum of 2 quarters · filed 2025-02-25 | $1.00B derived: sum of 3 quarters · filed 2025-02-25 | $1.00B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.00B derived: sum of 2 quarters · filed 2025-02-25 | $1.00B derived: sum of 3 quarters · filed 2025-02-25 | $2.25B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.00B derived: sum of 2 quarters · filed 2023-11-03 | $2.25B 10-Q · filed 2023-11-03 | $3.42B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.25B 10-Q · filed 2023-08-07 | $2.42B derived: sum of 3 quarters · filed 2024-02-26 | $2.42B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $1.25B 10-Q · filed 2023-05-05 | $2.42B derived: sum of 2 quarters · filed 2024-02-26 | $2.42B derived: sum of 3 quarters · filed 2024-02-26 | $2.42B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $1.17B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $1.17B derived: sum of 2 quarters · filed 2024-02-26 | $1.17B derived: sum of 3 quarters · filed 2024-02-26 | $2.32B 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $1.15B 10-Q · filed 2022-11-03 | $1.16B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.15B 10-Q · filed 2022-08-05 | $1.16B derived: sum of 3 quarters · filed 2023-02-24 | $1.16B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $1.15B 10-Q · filed 2022-05-05 | $1.16B derived: sum of 2 quarters · filed 2023-02-24 | $1.16B derived: sum of 3 quarters · filed 2023-02-24 | $1.16B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2020-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $5.00M derived: sum of 2 quarters · filed 2023-02-24 | $6.00M derived: sum of 3 quarters · filed 2023-02-24 | $1.96B 10-K · filed 2023-02-24 | ||||
| 2020-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $3.00M derived: sum of 2 quarters · filed 2021-11-05 | $1.95B 10-Q · filed 2021-11-05 | $1.95B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.95B 10-Q · filed 2021-08-09 | $1.95B derived: sum of 3 quarters · filed 2022-02-25 | $1.95B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $1.95B 10-Q · filed 2021-05-05 | $1.95B derived: sum of 2 quarters · filed 2022-02-25 | $1.95B derived: sum of 3 quarters · filed 2022-02-25 | $1.95B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $0.00 derived: sum of 2 quarters · filed 2022-02-25 | $0.00 derived: sum of 3 quarters · filed 2022-02-25 | $0.00 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $1.28B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $1.28B derived: sum of 3 quarters · filed 2021-02-25 | $1.28B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-06 | $1.28B derived: sum of 2 quarters · filed 2021-02-25 | $1.28B derived: sum of 3 quarters · filed 2021-02-25 | $3.28B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $1.28B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.28B derived: sum of 2 quarters · filed 2021-02-25 | $3.28B derived: sum of 3 quarters · filed 2021-02-25 | $4.29B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.00B derived: sum of 2 quarters · filed 2019-11-05 | $3.01B 10-Q · filed 2019-11-05 | $3.81B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $2.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.01B 10-Q · filed 2019-08-06 | $3.81B derived: sum of 3 quarters · filed 2020-02-26 | $3.81B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $1.00B 10-Q · filed 2019-05-08 | $1.80B derived: sum of 2 quarters · filed 2020-02-26 | $1.80B derived: sum of 3 quarters · filed 2020-02-26 | $1.81B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $802.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $802.00M derived: sum of 2 quarters · filed 2020-02-26 | $803.00M derived: sum of 3 quarters · filed 2020-02-26 | $1.10B 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.00M derived: sum of 2 quarters · filed 2018-11-06 | $301.00M 10-Q · filed 2018-11-06 | $301.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $301.00M 10-Q · filed 2018-08-07 | $301.00M derived: sum of 3 quarters · filed 2019-02-27 | $336.00M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $300.00M 10-Q · filed 2018-05-08 | $300.00M derived: sum of 2 quarters · filed 2019-02-27 | $335.00M derived: sum of 3 quarters · filed 2019-02-27 | $1.83B derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $35.00M derived: sum of 2 quarters · filed 2019-02-27 | $1.53B derived: sum of 3 quarters · filed 2019-02-27 | $2.39B 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.53B derived: sum of 2 quarters · filed 2017-11-07 | $2.39B 10-Q · filed 2017-11-07 | $2.39B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $1.50B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $2.35B 10-Q · filed 2017-08-08 | $2.35B derived: sum of 3 quarters · filed 2018-02-27 | $2.35B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $851.00M 10-Q · filed 2017-05-09 | $852.00M derived: sum of 2 quarters · filed 2018-02-27 | $852.00M derived: sum of 3 quarters · filed 2018-02-27 | $855.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.00M derived: sum of 2 quarters · filed 2018-02-27 | $4.00M derived: sum of 3 quarters · filed 2018-02-27 | $2.91B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $3.00M derived: sum of 2 quarters · filed 2016-11-07 | $2.90B 10-Q · filed 2016-11-07 | $9.52B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $2.90B 10-Q · filed 2016-08-08 | $9.52B derived: sum of 3 quarters · filed 2017-02-28 | $9.52B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $2.90B 10-Q · filed 2016-05-09 | $9.51B derived: sum of 2 quarters · filed 2017-02-28 | $9.51B derived: sum of 3 quarters · filed 2017-02-28 | $9.52B derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $6.61B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $6.61B derived: sum of 2 quarters · filed 2017-02-28 | $6.61B derived: sum of 3 quarters · filed 2017-02-28 | $6.62B 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $4.00M derived: sum of 2 quarters · filed 2015-11-05 | $7.00M 10-Q · filed 2015-11-05 | $1.27B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $5.00M 10-Q · filed 2015-08-06 | $1.26B derived: sum of 3 quarters · filed 2016-02-26 | $1.26B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $3.00M 10-Q · filed 2015-05-07 | $1.26B derived: sum of 2 quarters · filed 2016-02-26 | $1.26B derived: sum of 3 quarters · filed 2016-02-26 | $1.27B derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.26B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $1.26B derived: sum of 2 quarters · filed 2016-02-26 | $1.27B derived: sum of 3 quarters · filed 2016-02-26 | $1.77B 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $9.00M derived: sum of 2 quarters · filed 2014-11-10 | $515.00M 10-Q · filed 2014-11-10 | $533.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $515.00M 10-Q · filed 2014-08-07 | $533.00M derived: sum of 3 quarters · filed 2015-02-27 | $535.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $506.00M 10-Q · filed 2014-05-08 | $524.00M derived: sum of 2 quarters · filed 2015-02-27 | $526.00M derived: sum of 3 quarters · filed 2015-02-27 | $526.00M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $18.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $20.00M derived: sum of 2 quarters · filed 2015-02-27 | $20.00M derived: sum of 3 quarters · filed 2015-02-27 | $22.00M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.00M derived: sum of 2 quarters · filed 2013-11-07 | $4.00M 10-Q · filed 2013-11-07 | $274.00M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $2.00M 10-Q · filed 2013-08-07 | $272.00M derived: sum of 3 quarters · filed 2014-02-27 | $284.00M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | $2.00M 10-Q · filed 2013-05-09 | $272.00M derived: sum of 2 quarters · filed 2014-02-27 | $284.00M derived: sum of 3 quarters · filed 2014-02-27 | $1.54B derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2011-12-31 | $270.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $282.00M derived: sum of 2 quarters · filed 2014-02-27 | $1.54B derived: sum of 3 quarters · filed 2014-02-27 | $1.55B 10-K · filed 2014-02-27 | ||||
| 2011-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.27B derived: sum of 2 quarters · filed 2012-11-09 | $1.28B 10-Q · filed 2012-11-09 | $1.93B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $1.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $1.26B 10-Q · filed 2012-08-07 | $1.92B derived: sum of 3 quarters · filed 2013-02-28 | $1.98B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $4.00M 10-Q · filed 2011-05-09 | $656.00M derived: sum of 2 quarters · filed 2013-02-28 | $719.00M derived: sum of 3 quarters · filed 2013-02-28 | $723.00M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $652.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $715.00M derived: sum of 2 quarters · filed 2013-02-28 | $719.00M derived: sum of 3 quarters · filed 2013-02-28 | $1.34B 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $63.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $67.00M derived: sum of 2 quarters · filed 2011-11-08 | $689.00M 10-Q · filed 2011-11-08 | $689.30M 10-Q · filed 2010-11-08 | $689.30M derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $626.00M 10-Q · filed 2011-08-08 | $626.10M 10-Q · filed 2010-08-06 | $626.30M derived: sum of 3 quarters · filed 2012-02-28 | $643.50M derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-03-31 | $622.00M 10-Q · filed 2011-05-09 | $622.30M 10-Q · filed 2010-05-07 | $622.30M derived: sum of 2 quarters · filed 2012-02-28 | $639.50M derived: sum of 3 quarters · filed 2012-02-28 | $639.50M derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2009-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $17.50M derived: sum of 2 quarters · filed 2012-02-28 | $17.50M derived: sum of 3 quarters · filed 2012-02-28 | $25.00M 10-K · filed 2012-02-28 | $25.30M 10-K · filed 2010-03-01 | |||
| 2009-09-30 | $17.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $17.20M derived: sum of 2 quarters · filed 2010-11-08 | $24.70M 10-Q · filed 2010-11-08 | $71.00M 10-Q · filed 2009-10-29 | $625.70M derived: sum of 4 quarters · filed 2011-02-28 | |||
| 2009-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-06 | $7.50M 10-Q · filed 2010-08-06 | $71.00M 10-Q · filed 2009-07-24 | $608.50M derived: sum of 3 quarters · filed 2011-02-28 | $1.07B derived: sum of 4 quarters · filed 2011-02-28 | |||
| 2009-03-31 | $7.50M 10-Q · filed 2010-05-07 | $608.50M derived: sum of 2 quarters · filed 2011-02-28 | $1.07B derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | $601.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $1.07B derived: sum of 2 quarters · filed 2011-02-28 | $1.39B 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | $466.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | $791.00M 10-Q · filed 2009-10-29 | ||||||
| 2008-06-30 | $325.00M 10-Q · filed 2009-07-24 | |||||||
| 2007-12-31 | $1.20B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |